Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1147-1162
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1147
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1147
Figure 9 Histology of pancreas of rats subjected to 2,4,6-trinitrobenzene sulfonic acid.
All groups showing normal pancreas architecture without any evidence of pancreatitis. HC: Healthy control; DC: Disease control; BBA: β-boswellic acid; SLZ: Sulfasalazine; BH: Prodrug of BBA with L-histidine; BP: Prodrug of BBA with D-phenylalanine; BT: Prodrug of BBA with L-tryptophan; BTY: Prodrug of BBA with L-tyrosine; H: L-histidine; P: D-phenylalanine; T: L-tryptophan; TY: L-tyrosine; BBA + H: Physical mixture of BBA + L-histidine; BBA + P: Physical mixture of BBA + D-phenylalanine; BBA + T: Physical mixture of BBA + L-tryptophan; BBA + TY: Physical mixture of BBA + L-tyrosine.
- Citation: Sarkate A, Dhaneshwar SS. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation. World J Gastroenterol 2017; 23(7): 1147-1162
- URL: https://www.wjgnet.com/1007-9327/full/v23/i7/1147.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i7.1147